3rd Aug 2026 20:56
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Its North American licensing partner, Cizzle Bio Inc, announces it has executed a strategic laboratory agreement with BioBridge Global, a San Antonio-based healthcare services organisation with expertise in laboratory medicine, bio-manufacturing, blood banking and translational science. This is the second commercial agreement with a clinical laboratory group as Crizzle Bio rolls out its implementation programme to deliver the company's proprietary CIZ1B biomarker blood test for lung cancer. Under the agreement, BBG Advanced Therapies, a subsidiary of BBG, will serve as a clinical laboratory improvement amendments certified laboratory partner offering the test for lung cancer to licensed healthcare providers across South Texas. The agreement is part of a wider strategy to build a network of high-quality laboratory partners offering the test to licensed healthcare providers across the US.
----------
Image Scan Holdings PLC - Leicestershire, England-based provider of X-ray screening systems - Agrees to buy security technology business ClanTect Ltd from Stephen Daley, Ilias Zazas and University of Southampton Holdings Ltd. The deal is valued at between GBP900,000 to GBP1 million, including GBP600,000 of cash held on ClanTect's balance sheet. An initial GBP172,000 is payable in three instalments, plus contingent earn-out consideration, with the acquisition to be funded from the existing cash resources. ClanTect is expected to make a modest revenue contribution during FY2026, with substantial longer-term growth potential through Image Scan's global distribution network.
----------
GSTechnologies Ltd - Perth, Australia-based fintech company - Announces that it has drawn down the second USD5 million tranche of the USD10 million unsecured term loan facility entered into with Clarivan Group Kommanditbolag in June. The facility is therefore now fully drawn down.
----------
Anglesey Mining PLC - UK-based mineral exploration and development company - Outlines the investment case for Parys Mountain, the primary focus for Anglesey and one of the UK's most advanced brownfield mine development opportunities. Calls it an "advanced, well-established asset" with over 70 kilometres of drilling across 359 diamond drill holes supporting a JORC-compliant mineral resource exceeding 16 million tonnes. Notes it is metallurgically de-risked with infrastructure already in place. Anglesey says it is a "recapitalised and restructured company in a stronger economic market" with around GBP4 million debt eliminated over the past year and a complete refocus on Parys Mountain as the sole strategic asset. "With a simplified balance sheet, a single strategic focus, substantially higher metal prices than in 2021 and modern processing technology offering further recovery upside, we believe there is greater upside in Parys Mountain than the market currently recognises," says Chief Executive Andrew Fulton.
----------
Celsius Resources Ltd - developer of the Maalinao-Caigutan-Biyog copper-gold project in the Philippines - Advises that it has filed a criminal complaint against Attorney Julito "Sarge" Sarmiento, the former executive chair of Celsius, before the Philippine Department of Justice. Celsius says it has concerns around the conduct of Sarmiento including with respect to potential contraventions of law, the management of conflicts, including a disputed finder's fee, breaches of confidentiality and fiduciary duties as well as potential violations of professional responsibility and accountability rules. Celsius says it is also aware that certain parties within the Philippines have been spreading "misinformation" around its intentions with respect to the MCB project. It confirms it remains focused on progressing the financing and development of the project and is seeking further talks.
----------
Hercules PLC - Cirencester, England-based labour supply company for the UK infrastructure and construction sectors - Announces the launch of a dedicated Power & Energy Services division, which will sit alongside Labour Supply Services and Construction Services as one of the group's three core service divisions. Each division will be reported separately in the company's financial results announcements, providing greater visibility of their individual performance and growth. The decision reflects the strong momentum Hercules is experiencing in UK long-term infrastructure markets and an ambition to accelerate growth. Hercules has appointed Marcus White as managing director of the division.
----------
Coiled Therapeutics PLC - London-based clinical stage oncology company - Announces that the first patient in the US has been dosed with its optimised lipid-based oral formulation of AO-252. Initial post-dose safety monitoring identified no treatment-related adverse safety findings. AO-252 is Coiled Therapeutics' brain-penetrant small molecule inhibitor of TACC3, currently in phase I clinical development in the US for patients with advanced solid tumours. The new lipid-based softgel formulation delivers AO-252 in a pre-dissolved system, and is designed to provide more consistent, dose-proportional absorption than the previous tablet formulation, which showed dose-dependent absorption limitations. Coiled Therapeutics expects initial safety and pharmacokinetic data from the new formulation in the fourth quarter. Subject to positive results, it expects these data sets to support continued engagement with pharmaceutical companies that have previously expressed interest in AO-252.
----------
Invinity Energy Systems PLC - manufacturer of utility-grade energy storage systems - Announces the sale of 43 megwatt hours of battery systems to Dairyland Power Cooperative for deployment across long duration energy storage projects in the US midwest. Invinity President Matt Harper says: "This is a major win for Invinity and another clear sign that demand for proven, flexible, durable storage solutions is accelerating in the United States." Harper adds: "With three US project wins in quick succession, we at Invinity are excited to be building real momentum and creating a stronger order book for our US-based manufacturing capacity."
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Cizzle BiotechImage Scan HoldingsGSTechnologiesAnglesey MiningCelsius Resources LimitedHercules PlcCoiled TheraInvinity Energy